Brief Communication: Impact of Pretreatment HIV-1 Drug Resistance on Virologic Outcomes in Ugandan Patients infected with Non-B HIV-1 Subtypes

AI Generated

www.researchsquare.comSubmitted April 19, 2026

Background Pretreatment HIV-1 drug resistance (PDR), including minority variants, may compromise antiretroviral therapy (ART) outcomes but remains underexplored in non-B HIV-1 subtypes.Methods This longitudinal study enrolled 106 ART-naïve Ugandan adults (2018&nda...

The Verdict

ClassificationAI Generated

ConfidenceHigh confidence

Analyzedtext

Community Verdict

Be the first to vote on this assessment.

Embed Badge

Add this badge to your site to show the AI classification for this content.

[![Real Press](https://real.press/api/badge/8e1c50bc-6629-466a-a23d-e9a1018aef7e)](https://real.press/content/8e1c50bc-6629-466a-a23d-e9a1018aef7e)